{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:49:24Z","timestamp":1781592564320,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jacl.2022.10.005","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T13:55:51Z","timestamp":1667570151000},"page":"68-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Tsuyoshi","family":"Nozue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-1809","authenticated-orcid":false,"given":"Hayato","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8795-5712","authenticated-orcid":false,"given":"Masami","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Michishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2022.10.005_bib0001","doi-asserted-by":"crossref","first-page":"883","DOI":"10.5551\/jat.RV17054","article-title":"Current diagnosis and management of primary chylomicronemia","volume":"28","author":"Okazaki","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2022.10.005_bib0002","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1611930","article-title":"Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia","volume":"376","author":"Beigneux","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2022.10.005_bib0003","article-title":"Anti-GPIHBP1 antibody-positive autoimmune hyperchylomicronemia and immune thrombocytopenia","author":"Tanaka","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2022.10.005_bib0004","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ped.14154","article-title":"Acquired marked hypertriglyceridemia with anti-GPIHBP1 antibodies","volume":"62","author":"Imai","year":"2020","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jacl.2022.10.005_bib0005","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/L20-0327","article-title":"Chylomicronemia from GPIHBP1 autoantibodies successfully treated with rituximab: a case report","volume":"173","author":"Lutz","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2022.10.005_bib0006","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacl.2017.05.017","article-title":"GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia","volume":"11","author":"Hu","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2022.10.005_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacl.2018.10.004","article-title":"GPIHBP1 autoantibody syndrome during interferon beta1a treatment","volume":"13","author":"Eguchi","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2022.10.005_bib0008","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7326\/M19-0203","article-title":"The chylomicronemia syndrome is most often multifactorial: a narrative review of causes and treatment","volume":"170","author":"Chait","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2022.10.005_bib0009","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.10.005_bib0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jacl.2017.10.022","article-title":"An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum","volume":"12","author":"Miyashita","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2022.10.005_bib0011","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.2007.03075.x","article-title":"Genetic developments in autoimmune thyroid disease: an evolutionary process","volume":"68","author":"Zeitlin","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacl.2022.10.005_bib0012","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000078438","article-title":"Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2)","volume":"11","author":"Phenekos","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jacl.2022.10.005_bib0013","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2265.2012.04397.x","article-title":"Thyrotropin receptor antibody characteristics in a woman with long standing Hashimoto's who developed Graves' disease and pretibial myxedema","volume":"77","author":"Kamath","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jacl.2022.10.005_bib0014","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/1756-0500-7-489","article-title":"Conversion of autoimmune hypothyroidism to hyperthyroidism","volume":"7","author":"Furqan","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jacl.2022.10.005_bib0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jacl.2020.01.012","article-title":"Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies","volume":"14","author":"Ashraf","year":"2020","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2022.10.005_bib0016","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1194\/jlr.R120001116","article-title":"Chylomicronemia from GPIHBP1 autoantibodies","volume":"61","author":"Miyashita","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2022.10.005_bib0017","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.3390\/ijms20112760","article-title":"Evolution and medical significance of LU domain-containing proteins","volume":"20","author":"Leth","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2022.10.005_bib0018","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/trf.13584","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.jacl.2022.10.005_bib0019","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1210\/en.2002-0069","article-title":"The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors","volume":"144","author":"Schwarz-Lauer","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacl.2022.10.005_bib0020","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1210\/en.2012-1822","article-title":"Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms","volume":"154","author":"Hamidi","year":"2013","journal-title":"Endocrinology"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742200294X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742200294X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:38:41Z","timestamp":1761831521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742200294X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S193328742200294X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2022.10.005","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}